"GTP Phosphohydrolases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-.
| Descriptor ID |
D020558
|
| MeSH Number(s) |
D08.811.277.040.330
|
| Concept/Terms |
GTP Phosphohydrolases- GTP Phosphohydrolases
- Phosphohydrolases, GTP
- GTPase
- GTPases
- Guanosinetriphosphatases
- Guanosine Triphosphate Phosphohydrolases
- Phosphohydrolases, Guanosine Triphosphate
- Triphosphate Phosphohydrolases, Guanosine
- GTP Phosphohydrolase
- Phosphohydrolase, GTP
|
Below are MeSH descriptors whose meaning is more general than "GTP Phosphohydrolases".
Below are MeSH descriptors whose meaning is more specific than "GTP Phosphohydrolases".
This graph shows the total number of publications written about "GTP Phosphohydrolases" by people in this website by year, and whether "GTP Phosphohydrolases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 4 | 3 | 7 |
| 1999 | 3 | 1 | 4 |
| 2000 | 3 | 1 | 4 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 1 | 2 |
| 2009 | 3 | 1 | 4 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 3 | 6 |
| 2014 | 2 | 4 | 6 |
| 2015 | 3 | 4 | 7 |
| 2016 | 6 | 0 | 6 |
| 2017 | 3 | 0 | 3 |
| 2018 | 5 | 2 | 7 |
| 2019 | 4 | 3 | 7 |
| 2020 | 0 | 2 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "GTP Phosphohydrolases" by people in Profiles.
-
Leukocytosis and Splenomegaly in a Neonate With NRAS Mutation. Clin Pediatr (Phila). 2024 05; 63(4):451-455.
-
Computational investigation to identify potent inhibitors of the GTPase-Kirsten RAt sarcoma virus (K-Ras) mutants G12C and G12D. Comput Biol Med. 2021 12; 139:104946.
-
Neurocutaneous Melanocytosis and Leptomeningeal Melanoma. J Pediatr Hematol Oncol. 2021 03 01; 43(2):e195-e197.
-
De novo missense variant in the GTPase effector domain (GED) of DNM1L leads to static encephalopathy and seizures. Cold Spring Harb Mol Case Stud. 2019 06; 5(3).
-
A Targeted Mutation Identified through pKa Measurements Indicates a Postrecruitment Role for Fis1 in Yeast Mitochondrial Fission. J Biol Chem. 2016 09 23; 291(39):20329-44.
-
ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas. Cancer Res. 2015 Sep 01; 75(17):3554-67.
-
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation. Cell Rep. 2015 Jul 21; 12(3):511-24.
-
Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders. Hematology Am Soc Hematol Educ Program. 2015; 2015:559-64.
-
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target. Clin Cancer Res. 2014 Nov 01; 20(21):5537-46.
-
Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation. Br J Haematol. 2014 Aug; 166(3):461-5.